I'm taking MEB off my watchlist. Could have another run next year again triggered by FDA developments. I was unimpressed that they decided not to proceed with seeking FDA approval for one of their products which was announced during the week. The rationale makes sense but that was one of the pieces of news which was a potential share price driver this year. Good luck with the next run. Hope it isn't too long for you.
